umu.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
L-DOPA-Coated Manganese Oxide Nanoparticles as Dual MRI Contrast Agents and Drug-Delivery Vehicles
Show others and affiliations
2016 (English)In: Small, ISSN 1613-6810, E-ISSN 1613-6829, Vol. 12, no 3, 301-306 p.Article in journal, Letter (Refereed) Published
Resource type
Text
Abstract [en]

Manganese oxide nanoparticles (MONPs) are capable of time-dependent magnetic resonance imaging contrast switching as well as releasing a surface-bound drug. MONPs give T2/T2* contrast, but dissolve and release T1-active Mn2+ and l-3,4-dihydroxyphenylalanine. Complementary images are acquired with a single contrast agent, and applications toward Parkinson's disease are suggested.

Place, publisher, year, edition, pages
2016. Vol. 12, no 3, 301-306 p.
National Category
Cancer and Oncology
Identifiers
URN: urn:nbn:se:umu:diva-116741DOI: 10.1002/smll.201502545ISI: 000368707800003PubMedID: 26619158OAI: oai:DiVA.org:umu-116741DiVA: diva2:904821
Available from: 2016-02-19 Created: 2016-02-11 Last updated: 2017-05-11Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Sandvig, Axel
By organisation
Clinical Neuroscience
In the same journal
Small
Cancer and Oncology

Search outside of DiVA

GoogleGoogle Scholar

Altmetric score

Total: 33 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf